Press Release

Analysis of RNA-interference (RNAi) Market 2019-2024: Industry Trends, Share, Size, Price, Revenue, Business Strategy, Production Technology Forecast to 2024

RNA-interference

The “RNA-interference (RNAi) Market” research report 2019 delivers comprehensive information about the market ranging from the establishment to the predictable growth trend. RNA-interference (RNAi) market report provides brief analytical data of the market contenders globally using advanced methodological approaches, such as SWOT analysis, production chain, cost, sales margin, financial details, recent developments. RNA-interference (RNAi) market report also offers market competitors that includes detailed company profiles along with company product specifications.

Market Overview:

  • The RNA-interference (RNAi) market is expected to witness a CAGR of 20.2% during the forecast period. Certain factors that are driving the market growth include the increasing number of applications in molecular diagnostics, particularly in cancer and improving synthetic delivery carriers and chemical modifications to RNA.
  • Cancer diagnosis and treatment is currently undergoing a shift with the incorporation of RNAi techniques in personalized medicine and molecular diagnostics. The availability of high throughput techniques for the identification of altered cellular molecules and metabolites allows the use of RNAi techniques in various cancer diagnosis and targeting approaches. For diagnostic purposes, small interfering RNAs (siRNA) or microRNAs (miRNA) can be utilized. The commercial availability of siRNAs to silence virtually any gene in the human genome is dramatically accelerating the pace of molecular diagnosis and biomedical research. Thus, increasing the application of RNAi in molecular diagnosis and its viability as a therapeutic technique is expected to drive the growth of the RNAi market during the forecast period.
  • However, in recent years, there has been a decline in FDA drug approval rates. Getting FDA approval for a new drug has become extremely challenging. It approved less than half the number of new drugs in 2016 (19 so far) when compared to 2015 (45 total) and 2014 (41 total). Hence, despite the large investments, there has been a decline in the number of innovative drugs manufactured. FDA explains manufacturing standards and other complying issues as the major reasons for this declining trend. This can impede the growth of the RNAi therapeutics, especially since the miRNAs and siRNAs fall into the relatively new field of genetic medicine, wherein they may require more intensified clinical trials. The highly extensive clinical trials effectively result in low approval rates of drugs. This would mean that the stringent guidelines will be a major restraint for the growth of the market.

    Get a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/14244605

    In RNA-interference (RNAi) Market Report, Following Companies Are Covered:

  • Alnylam Pharmaceuticals
  • Arcturus Therapeutics
  • Arrowhead
  • Dicerna Pharmaceuticals
  • Ionis Pharmaceuticals Inc.
  • Merck & Co. Inc. (Sigma Aldrich)
  • Qiagen NV
  • Thermo Fisher Scientific Inc.
  • Quark Pharmaceuticals Inc.
  • Silence Therapeutics PLC
  • Phio Pharmaceuticals Corp.

    RNA-interference (RNAi) Market 2019 report will help the industry aspirants in arranging their strategies. The measurements offered in this report will be an exact and helpful manual to shape the business development. Additionally, will Provide historical data along with a future forecast and detailed analysis and also expected opportunities.

    Scope of the Report:

  • RNA interference is a biological process in which the RNA molecules are observed to inhibit gene expression or translation, by neutralizing the targeted mRNA molecules. Earlier, RNAi was identified by other names, such as co-suppression, post-transcriptional gene silencing (PTGS), and quelling. The extensive study of each of these apparently different processes clarified that the identity of these phenomena were all in fact RNAi.

    Reasons for Buying RNA-interference (RNAi) Market Report:

    • This report provides pin-point analysis for changing competitive dynamics
    • It provides a forward looking perspective on different factors driving or restraining market growth
    • It provides a five-year forecast assessed on the basis of how the market is predicted to grow
    • It helps in understanding the key product segments and their future
    • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
    • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

    For More Information or Query or Customization Before Buying, Visit at – https://www.industryresearch.co/enquiry/pre-order-enquiry/14244605

    Key Market Trends:

    Oncology is Expected to Hold Significant Market Share in the Therapeutics Type

    According to the World Health Organization, cancer is the second leading cause of death worldwide and was responsible for 8.8 million deaths in 2015. Globally, nearly one in six deaths can be attributed to cancer. Cancer is one of the leading causes of morbidity and mortality across the globe, with approximately 14 million new cases in 2012. The number of new cases is expected to rise by about 70% over the next two decades.

    Recent advancements, such as the development of small interfering RNA (siRNA) tolerant to nucleases and the development of non-viral vectors, such as cationic liposomes and nanoparticles, can overcome this obstacle and facilitate the clinical use of RNAi-based therapeutics in the treatment of cancer. These developments are anticipated to help the growth of the global market in the large cancer therapy market.

    North America Dominates the Market and Expected to do the Same in the Forecast Period

    There are a large number of companies and research institutes in the country, increasingly investing in research on drug discovery using RNAi technology. The recent technological and medical advances are available in North America. Other factors, such as the growing population and high incidences of diseases, such as liver disorders and cancers, are fuelling the regional growth of this market.

    The Research Document Will Answer Following Questions Such as:

    • What are the cutting-edge technologies responsible for driving the growth of the market?
    • What are the main applications of the market? What are the growth prospects to the market applications into the market?
    • At what stage of development are the key market products?
    • What are the shortcomings that has to face to become commercially viable? Is their growth and commercialization dependent on cost declines or technological/application breakthroughs?
    • What is the outlook for the industry?
    • What difference does performance characteristics of RNA-interference (RNAi) create from those of established entities?

    Purchase this Report (Price 4250 USD for single user license) – https://www.industryresearch.co/purchase/14244605

    Detailed TOC of RNA-interference (RNAi) Market Report 2019-2024:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Increasing Number of Applications in Molecular Diagnostics, Particularly in Cancer
    4.2.2 Improving Synthetic Delivery Carriers and Chemical Modifications to RNA
    4.3 Market Restraints
    4.3.1 Stringent FDA Regulations and Changing Reimbursement Environment
    4.3.2 Unstable Potentially Immunogenic Nature of RNA
    4.4 Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION
    5.1 Application
    5.1.1 Drug Discovery and Development
    5.1.2 Therapeutics
    5.1.2.1 Oncology
    5.1.2.2 Ocular Disorders
    5.1.2.3 Respiratory Disorders
    5.1.2.4 Hepatitis B and C
    5.1.2.5 Autoimmune Hepatitis
    5.1.2.6 Neurological Disorders
    5.1.2.7 Other Therapeutics
    5.1.3 Other Applications
    5.2 Geography
    5.2.1 North America
    5.2.1.1 US
    5.2.1.2 Canada
    5.2.1.3 Mexico
    5.2.2 Europe
    5.2.2.1 Germany
    5.2.2.2 UK
    5.2.2.3 France
    5.2.2.4 Italy
    5.2.2.5 Spain
    5.2.2.6 Rest of Europe
    5.2.3 Asia-Pacific
    5.2.3.1 China
    5.2.3.2 Japan
    5.2.3.3 India
    5.2.3.4 Australia
    5.2.3.5 South Korea
    5.2.3.6 Rest of Asia-Pacific
    5.2.4 Middle East & Africa
    5.2.4.1 GCC
    5.2.4.2 South Africa
    5.2.4.3 Rest of Middle East & Africa
    5.2.5 South America
    5.2.5.1 Brazil
    5.2.5.2 Argentina
    5.2.5.3 Rest of South America

    6 COMPETITIVE LANDSCAPE
    6.1 Company Profiles
    6.1.1 Alnylam Pharmaceuticals
    6.1.2 Arcturus Therapeutics
    6.1.3 Arrowhead
    6.1.4 Dicerna Pharmaceuticals
    6.1.5 Quark Pharmaceuticals Inc.
    6.1.6 Ionis Pharmaceuticals Inc.
    6.1.7 Merck & Co. Inc. (Sigma Aldrich)
    6.1.8 Silence Therapeutics PLC
    6.1.9 Qiagen NV
    6.1.10 Phio Pharmaceuticals Corp.
    6.1.11 Thermo Fisher Scientific Inc.

    7 MARKET OPPORTUNITIES AND FUTURE TRENDS

     

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Global Medical X-ray Film Market 2019: Industry Size & Share, Business Strategies, Growth Analysis, Regional Demand, Revenue, Key Manufacturers and 2024 Forecast Research Report

    Pool Barrier Market 2019 Industry Business Challenges, Share, Geographical Segmentation, Consumption Status and Opportunity Analysis: World Market Outlook to 2024

    Fabric Conditioner Market Analysis 2019 to 2025: Report Includes Threat of New Entrants, Demand & Supply, Investment Opportunities and Forecast

    Automotive eCall Market 2019-2025 | Report includes Industrial potential Growth with Market share analysis and also include Key Players, Industry Challenges, Key Vendors, Drivers, Trends

    Tags
  • Alfredoo Epps

    Alfredo Epps is a finance expert heading the petroleum column. He joined the group last year as an associate writer. But his thorough research skills and ability to seamlessly putting numerical data into words helped him get a senior position. Apart from a column head, Alfredo is a dancer and a violinist.

    Related Articles

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    Close